KLK4 and diabetic kidney disease: In addition, exogenous kallikrein resulted in a decreased glomerular basement membrane thickness and protected against the loss of endothelial fenestrae, loss of podocytes, the effacement of foot processes in diabetic mice, and ultimately mitigated diabetic nephropathy [72].